Skip to content

Clinical trials

Primary Myelofibrosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: South Korea Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20111
20131
20152
20173
20181
20192
20205
202110
20232
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting11
Recruiting7
Terminated4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Novartis Pharmaceuticals4
Incyte Corporation3
Asan Medical Center2
Bristol-Myers Squibb2
Celgene2
Geron Corporation2
Kartos Therapeutics, Inc.2
Karyopharm Therapeutics Inc2
Sierra Oncology LLC - a GSK company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis36
Myeloproliferative Disorders11
Neoplasms6
Anemia5
Leukemia, Myeloid, Acute4
Leukemia, Myelomonocytic, Chronic3
Polycythemia Vera3
Blast Crisis2
Bone Marrow Diseases2
Burkitt Lymphoma2

Trials

Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.